RDNZ’s feedback on the proposal to fund Trikafta for people wih cystic fibrosis
![trikafta v2](/assets/Uploads/trikafta-v2__FitWzM3MCwyNzBd.jpg)
RDNZ provided feedback under Pharmac's consultation process on the proposal to fund Trikafta for people with cystic fibrosis (CF) aged 6 years and over from 1 April 2023.
Read the full submission here.